Sutro Biopharma, Inc.
(NASDAQ: STRO)

Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.

8.770

-0.610 (-6.50%)
Range 8.720 - 9.240   (5.96%)
Open 9.200
Previous Close 9.380
Bid Price 5.050
Bid Volume 8
Ask Price 5.440
Ask Volume 9
Volume 24,457
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 23:06.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis